Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hector Perez-Montoyo (Héctor Perez-Montoyo, Héctor Pérez-Montoyo)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Signaling Pathway

Endometrial Cancer

Endoplasmic Reticulum

Top Venues

Cellular and molecular life sciences : CMLS

EMBO molecular medicine

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Marina Ciscar, Eva María Trinidad, Gema Perez-Chacon, Mansour A Alsaleem, Maria Jimenez, Maria J Jimenez-Santos, Hector Perez-Montoyo, Adrián Sanz-Moreno, Andrea Vethencourt, Michael S Toss, Anna Petit, Maria T Soler-Monso, Victor Lopez, Jorge Gómez-Miragaya, Clara Gomez-Aleza, Lacey E Dobrolecki, Michael T Lewis, Alejandra Bruna, Silvana Mouron, Miguel Quintela-Fandino, Fatima Al-Shahrour, Antonio Martinez-Aranda, Angels Sierra, Andrew R Green, Emad Rakha, Eva Gonzalez Suarez
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer. EMBO molecular medicine (2023)
Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Muñoz-Guardiola, Elisabet Megías-Roda, Hector Perez-Montoyo, Marc Yeste-Velasco, Jose Alfón, Jose Miguel Lizcano, Carles Domènech, Santiago Ruiz-Martínez, Teresa Puig Miquel
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models. Cancer communications (London, England) 42 (6) (2022)
Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megías-Roda, Idoia Bolinaga-Ayala, Maria Viñas-Casas, Gökhan Görgişen, Inés Domingo-Ortí, Hector Perez-Montoyo, José-Ramón Bayascas, Eva Colás, Xavier Dolcet, Jose Miguel Lizcano
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival. Cellular and molecular life sciences : CMLS 79 (10) (2022)